Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

1.8%

2 terminated/withdrawn out of 110 trials

Success Rate

97.1%

+10.6% vs industry average

Late-Stage Pipeline

31%

34 trials in Phase 3/4

Results Transparency

6%

4 of 66 completed trials have results

Key Signals

8 recruiting4 with results

Enrollment Performance

Analytics

N/A
38(48.1%)
Phase 4
28(35.4%)
Phase 3
6(7.6%)
Phase 2
5(6.3%)
Early Phase 1
1(1.3%)
Phase 1
1(1.3%)
79Total
N/A(38)
Phase 4(28)
Phase 3(6)
Phase 2(5)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (110)

Showing 20 of 110 trials
NCT06088121Not ApplicableRecruiting

Study to Evaluate the Efficacy and Safety of ATNC-MDD V1(TMS With Cognitive Training) in Mild Alzheimer's Dementia

Role: collaborator

NCT06330038Phase 4Recruiting

Anesthesia and Non-small Cell Lung Cancer Recurrence

Role: collaborator

NCT06035757Phase 4Recruiting

The Occurrence of Emergence Agitation in Pediatric Strabismus Surgery

Role: lead

NCT06637943Not Yet Recruiting

Comparison of the Diagnosis Time of VET and SCL in Patients With Intraoperative Coagulopathy

Role: lead

NCT04031144Not ApplicableCompleted

Ultrafiltration on Coagulation Function in Cardiac Surgery

Role: lead

NCT07154485Phase 2Not Yet Recruiting

Investigator Initiated Study for the Safety and Efficacy in Frontotemporal Dementia

Role: collaborator

NCT06144112Phase 4Not Yet Recruiting

Fibrinogen Concentrates Versus Cryoprecipitate in Liver Transplant Surgery

Role: lead

NCT04719936Not ApplicableCompleted

Superior and Inferior Capsulotomy in Bipolar Hemiarthroplasty Using Posterior Approach

Role: collaborator

NCT01518556Phase 1Completed

Safety and Efficacy Study of Idarubicin Dose Intensification to Treat Acute Myeloid Leukemia

Role: lead

NCT05883345Completed

Blood Tests for Gastritis and Gastric Neoplasms

Role: lead

NCT05806346Not ApplicableRecruiting

Goal-directed vs. Empirical Tranexamic Acid Administrationin Cardiovascular Surgery

Role: lead

NCT03753074Phase 4Active Not Recruiting

Effectiveness of TAF in Reducing Clinical Events in CHB Patients Beyond Treatment Indications by Current Guidelines

Role: collaborator

NCT06664320Not ApplicableNot Yet Recruiting

Mild ANH on Pre-bypass Coagulation Function During Cardiac Surgery

Role: lead

NCT04742660Not ApplicableCompleted

The Effect of Glycyrrhizin on the Occurrence of Postoperative Nausea and Vomiting

Role: lead

NCT02700607Not ApplicableCompleted

Impact of Intravascular Fluid Resuscitation and Whole Blood Viscosity

Role: lead

NCT06574594Not ApplicableRecruiting

Effect of MTX Discontinuation on Shingrix Response in RA

Role: lead

NCT05957822Phase 4Recruiting

Goal-directed vs Preemptive Tranexamic Acid Administration in Non-cardiac Surgery

Role: lead

NCT02800499Enrolling By Invitation

KOrea COpd Subgroup Registry and Subtype Research

Role: lead

NCT06077721Unknown

Milrinone on Right Ventricular Strain in Cardiac Surgery

Role: lead

NCT05956769Not ApplicableUnknown

Goal-directed vs Preemptive Tranexamic Acid Administration in Total Hip Arthroplasty

Role: lead